DDX10 c.1256del ;(p.L419Cfs*19)

Variant ID: 11-108577494-AT-A

NM_004398.2(DDX10):c.1256del;(p.L419Cfs*19)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Spred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line.

Translational Cancer Research
He, Zhiyong Z; Gong, Fusheng F; Liao, Jinrong J; Wang, Qiang Q; Su, Ying Y; Chen, Chao C; Lin, Jinghui J; Lin, Ren-Jang RJ
Publication Date: 2020-04

Variant appearance in text: DDX10: 1255delT
PubMed Link: 35117614
Variant Present in the following documents:
  • Main text
View BVdb publication page